Delta Medical in Belarus: Advancing Pharmaceutical Excellence
Belarus: A Key Pharmaceutical Market in Eastern Europe
Belarus, with a population of approximately 9.4 million, represents a significant opportunity for pharmaceutical companies.
The capital city, Minsk, is home to about 2 million residents, making it the largest urban center and a crucial hub for healthcare services and pharmaceutical distribution.
Other key cities in Belarus include:
- Gomel: Population ~510,000
- Mogilev: Population ~380,000
- Vitebsk: Population ~370,000
- Grodno: Population ~370,000
- Brest: Population ~350,000
These urban centers, along with smaller cities and rural areas, form the backbone of Delta Medical’s distribution network in Belarus.
Strategic Medical and Government Partnerships in Belarus
Delta Medical has forged strong collaborations with key stakeholders in the Belarusian healthcare sector, including:
- Ministry of Health of the Republic of Belarus
- Center for Examinations and Tests in Health Service
- National Academy of Sciences of Belarus
- Belarusian State Medical University
- Vitebsk State Medical University
- Republican Scientific and Practical Center for Epidemiology and Microbiology
- Belarusian Medical Academy of Postgraduate Education
These partnerships enable us to cooperate effectively and contribute to the advancement of medical care in Belarus.
Regulatory Expertise in Belarus
Our team of regulatory affairs specialists possesses in-depth knowledge of Belarus’s pharmaceutical regulations, ensuring compliance with:
- Law of the Republic of Belarus “On Medicinal Products”
- Good Manufacturing Practices (GMP) standards
- Eurasian Economic Union (EAEU) regulations
- Pharmacovigilance requirements set by the Ministry of Health
- Regulations on medical devices and health supplements
Comprehensive Registration Services
Delta Medical offers streamlined registration services for a wide range of products:
- Finished medicinal products
- Active pharmaceutical ingredients
- Medical devices and equipment
- Health supplements and specialized nutrition products
- Biologically active additives
Our expertise in the registration process helps expedite market entry for innovative therapies and essential medications, ensuring Belarusian patients have access to the latest healthcare solutions.
Extensive Belarus Distribution Network
Delta Medical has established a robust distribution network that spans major Belarusian cities, ensuring timely delivery of pharmaceutical products to healthcare facilities and pharmacies.
Our distribution strategy leverages:
- Partnerships with local wholesalers and distributors
- Direct-to-pharmacy delivery systems
- Cold chain management for temperature-sensitive products
- Inventory management systems to prevent stockouts
- Collaboration with the Belarusian postal service for remote area deliveries
Notably, our distribution capabilities are enhanced by our strategic use of warehouses in the Baltic states, which provide convenient and efficient supply routes to Belarus.
This proximity allows for rapid restocking and reduces lead times, ensuring consistent product availability in the Belarusian market.
Market Access Strategies: Overcoming Challenges, Seizing Opportunities
Delta Medical implements tailored strategies to navigate Belarus’s unique market dynamics, including:
- Adapting to local pricing regulations and reimbursement policies
- Developing value propositions that resonate with Belarusian healthcare providers and payers
- Engaging in public-private partnerships to expand access to innovative therapies
- Participating in government tenders and procurement processes
- Collaborating with local scientific institutions for clinical research
Key Focus Areas
Our market access efforts in Belarus concentrate on:
- International consumer brands
- Innovative therapies for unmet medical needs
- Specialty pharmaceuticals for complex conditions
- Localization initiatives to align with government priorities
- Orphan drugs for rare diseases
Medical Affairs: Bridging Science and Clinical Practice
Delta Medical’s Medical Affairs team plays a crucial role in engaging with the Belarusian medical community.
Our activities include:
- Collaborating with Key Opinion Leaders (KOLs) and professors to share knowledge on the most current treatment regimens
- Organizing and participating in scientific symposia and medical conferences
- Facilitating the exchange of patient case studies among healthcare professionals
- Supporting investigator-initiated studies and clinical research initiatives
- Providing medical information services to healthcare providers
- Conducting real-world evidence studies to support product value
These efforts not only enhance the understanding and appropriate use of our products but also contribute to the overall advancement of medical knowledge in Belarus.
Pharmacovigilance: Ensuring Patient Safety
Our dedicated pharmacovigilance team in Belarus works diligently to:
- Monitor and report adverse events in compliance with local regulations
- Conduct post-marketing surveillance studies
- Collaborate with healthcare providers to ensure proper product use
- Liaise with regulatory authorities on safety-related matters
- Implement risk minimization measures when necessary
This commitment to pharmacovigilance underscores Delta Medical’s priority on patient safety and product quality, aligning with global best practices and local requirements.
Delta Medical’s Office in Minsk
Our company’s operations in Belarus are centered at our Minsk office, located at:
Delta Medical
Office 22,
31 Poligraficheskaia STR.
MINSK city, 220090
Belarus
Email: info-by@deltaswiss.eu
About Delta Medical
Delta Medical, headquartered in Zurich, Switzerland, is a leading pharmaceutical services company operating across Eastern Europe, the Caucasus, and Central Asia.
Established in 1999, we serve 13 countries including Ukraine, Kazakhstan, Uzbekistan, and Azerbaijan.
Our ISO 13485 and 22000 certifications, along with SwissMedic pharmaceutical licensing, und
erscore our commitment to quality.
As members of the Swiss Biotech Organization and Swiss Medical Technology Association, we specialize in market entry, regulatory affairs, and distribution for pharmaceuticals, medical devices, and nutraceuticals.
Delta Medical’s network reaches over 21,000 pharmacies and 2,150 hospitals, supported by 400+ healthcare specialists.
Our expertise spans oncology, nephrology, and rare diseases, with a focus on orphan drugs and biosimilars.
Pharmacovigilance System in Belarus
Pharmacovigilance (PVG), which involves monitoring the safety of medicines, is crucial for pharmaceutical companies to…